Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed newly diagnosed stage II or III neuroblastoma or ganglioneuroblastoma~  * Unresectable disease~* No MYCN amplification (i.e., fewer than 10 copies)~* No metastases to bone marrow~* No radiological bone lesions in skeleton~PATIENT CHARACTERISTICS:~Age:~* Under 12 months at diagnosis~Performance status:~* Not specified~Life expectancy:~* Not specified~Hematopoietic:~* Not specified~Hepatic:~* No evidence of liver disease by ultrasound~Renal:~* Not specified~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* Not specified~Endocrine therapy~* Not specified~Radiotherapy~* Not specified~Surgery~* Not specified

- Gender: ALL
- Minimum Age: None
- Maximum Age: 1 Year
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).